Cite
Stereotactic body radiotherapy of bone metastases in oligometastatic disease: Prognostic factors of oncologic outcomes
MLA
Ursino, S., et al. Stereotactic Body Radiotherapy of Bone Metastases in Oligometastatic Disease: Prognostic Factors of Oncologic Outcomes. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1383766316&authtype=sso&custid=ns315887.
APA
Ursino, S., Montrone, S., Cantarella, M., Menghini, V., Matteucci, F., Mazzotti, V., Fiorica, F., Fedele, D., Erba, P., Morganti, R., Fabrini, M., Caramella, D., Ursino S., Montrone S., Cantarella M., Menghini V., Matteucci F., Mazzotti V., Fiorica F., … Caramella D. (2016). Stereotactic body radiotherapy of bone metastases in oligometastatic disease: Prognostic factors of oncologic outcomes.
Chicago
Ursino, S, S Montrone, M Cantarella, V Menghini, F Matteucci, V Mazzotti, F Fiorica, et al. 2016. “Stereotactic Body Radiotherapy of Bone Metastases in Oligometastatic Disease: Prognostic Factors of Oncologic Outcomes.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1383766316&authtype=sso&custid=ns315887.